











































Analysis of complex DNA rearrangements during early stages of
HAC formation
Citation for published version:
Pesenti, E, Liskovykh, M, Okazaki, K, Mallozzi, A, Reid, C, Abad, MA, Jeyaprakash, AA, Kouprina, N,
Larionov, V, Masumoto, H & Earnshaw, WC 2020, 'Analysis of complex DNA rearrangements during early
stages of HAC formation', ACS Synthetic Biology, vol. 9, no. 12, pp. 3267-3287.
https://doi.org/10.1021/acssynbio.0c00326
Digital Object Identifier (DOI):
10.1021/acssynbio.0c00326
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 18. Feb. 2021
Analysis of Complex DNA Rearrangements during Early Stages of
HAC Formation
Elisa Pesenti,* Mikhail Liskovykh, Koei Okazaki, Alessio Mallozzi, Caitlin Reid, Maria Alba Abad,
A. Arockia Jeyaprakash, Natalay Kouprina, Vladimir Larionov, Hiroshi Masumoto,
and William C. Earnshaw*
Cite This: ACS Synth. Biol. 2020, 9, 3267−3287 Read Online
ACCESS Metrics & More Article Recommendations *sı Supporting Information
ABSTRACT: Human artificial chromosomes (HACs) are im-
portant tools for epigenetic engineering, for measuring chromo-
some instability (CIN), and for possible gene therapy. However,
their use in the latter is potentially limited because the input HAC-
seeding DNA can undergo an unpredictable series of rearrange-
ments during HAC formation. As a result, after transfection and
HAC formation, each cell clone contains a HAC with a unique
structure that cannot be precisely predicted from the structure of
the HAC-seeding DNA. Although it has been reported that these
rearrangements can happen, the timing and mechanism of their
formation has yet to be described. Here we synthesized a HAC-
seeding DNA with two distinct structural domains and introduced
it into HT1080 cells. We characterized a number of HAC-
containing clones and subclones to track DNA rearrangements during HAC establishment. We demonstrated that rearrangements
can occur early during HAC formation. Subsequently, the established HAC genomic organization is stably maintained across many
cell generations. Thus, early stages in HAC formation appear to at least occasionally involve a process of DNA shredding and
shuffling that resembles chromothripsis, an important hallmark of many cancer types. Understanding these events during HAC
formation has critical implications for future efforts aimed at synthesizing and exploiting synthetic human chromosomes.
KEYWORDS: centromere, human artificial chromosome, epigenetic engineering, mitosis, kinetochore, CENP-A
Human artificial chromosomes (HACs) are nonessentialmini-chromosomes that replicate and segregate correctly
in human cells.1 HACs made using synthetic centromeric DNA
have been extensively characterized and improved over the
past decade.2−5 They now represent an important tool to study
epigenetic regulation of centromere structure and func-
tion,2,6−10 to study full-length gene functions in mutant animal
or human cells,5,11−16 to measure chromosome instability
(CIN), and to identify new targets for cancer therapy.17−19
Also, synthetic HACs do not interfere with embryogenesis in
mice, making them a promising tool for future gene
therapeutic studies.15 Synthetic HACs were originally designed
using a “bottom up” approach to contain only predefined DNA
arrays.1,20,21 Their design allows the HAC centromeres to be
easily modified and inactivated/removed by targeting with
chimeric proteins specifically directed to the synthetic
DNA.2,4,11,14 However, they also present a number of
challenges that must be overcome to enable them to be
exploited fully.
HACs form in a complex and as-yet incompletely
characterized process after transfection of seeding DNA into
human cells. During this relatively lengthy period (typically ∼3
weeks), the HAC-seeding DNA undergoes spontaneous
multimerization and in at least some cases may pass through
a stage when it is transiently inserted into the arm of an
endogenous chromosome.3,22 The multimerization presumably
allows it to attain a threshold size required for stable
chromosome segregation.23 Only the alphoidtetO HAC has
previously been characterized in molecular detail. That analysis
found complex rearrangements in the organization of its
seeding DNA during this multimerization process, including
inversions and deletions.3 These rearrangements are unpre-
dictable and uncontrollable as they occur during the clonal
expansion before HAC-bearing cell lines are established and
identified. This is the time during which the HAC-seeding
DNA is forming a functional centromere, an absolute
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requirement for the DNA to be stably maintained in cells. As a
result, each HAC-bearing cell clone obtained after the selection
process contains a HAC that could potentially have a DNA
organization different from its sister clones. Although it is
known that rearrangements can happen,3 how and when they
occur remains unknown. Importantly, it is not known if these
Figure 1. Generation of synthetic α21-ITetO and α21-IILacO/Gal4 arrays. (A) Scheme of the pBAC11.32TW12.32GLII containing BAC and YAC
cassettes, G418 resistance cassette, and synthetic DNA: α21-ITetO formed by high ordered repeats (HOR) monomers (green arrows) containing
CENP-B boxes (blue) alternating with monomers containing TetO (yellow); α21-IILacO/Gal4 formed by high ordered repeats (HOR) monomers
(yellow arrows) containing Gal4 binding sequence (green) alternating with LacO (red). (B) Schematic of the assembly of the α21-ITetO and α21-
IILacO/Gal4 arrays. (C,D) PFGE analysis of the nascent α21-ITetO and α21-IILacO/Gal4 arrays, cut with BamHI/NotI after each cycles of tandem ligation
array amplification as described in Figure S2A (C) and Figure S2B (D). Expected sizes: α21-ITetO11-mer 1 copy (1.9 kb), 8 copies (15.2 kb), 32
copies (60.8 kb); α21-IILacO/Gal412-mer 1 copy (2 kb), 8 copies (16 kb), 32 copies (64 kb). Plasmid vector is 2.9 kb, BAC vector is 7.1 kb. The
asterisk (*) indicates the fragments that have been cloned into BAC vector (8 copies, 16 kb); red arrow in D indicates the size of the final
pBAC11.32TW12.32GLII (∼120 kb) (m and M, markers).
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Figure 2. Formation of input pBAC11.32TW12.32GLII DNA. (A) CHEF analysis of 16 bacterial DNA after transformation with
pBAC11.32TW12.32GLII and NotI and BamHI digestion: red arrows indicate the size of the final vector (∼120 kb); colonies labeled in red
contain the inset of the desired length. DNA used for transfection as a control (in duplicate) (M marker). (B) Scheme of the
pBAC11.32TW12.32GLII input DNA showing restriction sites for NotI and BamHI used to release the synthetic DNA. (C) PFGE analysis of
selected bacterial colonies (in red) digested with EcoRI: each fragment originates from a different array (label on the left). DNA used for
transfection as a control (in duplicate); original DNA as uncut sample (M marker). (D) α21-ITetO and α21-IILacO/Gal4DNA ratio calculated with
ImageJ on the intensity of the bands shown in C for each bacterial colony. Control and original DNA as in C. (E) CHEF analysis of bacterial
colony #1 DNA (in duplicate) digested with NotI and BamHI to release the synthetic DNA (m and M, markers).
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structural rearrangements are an obligate part of the selection
process that occurs during centromere formation.
To investigate further how and when rearrangements
happen, here we developed a novel alphoid2domain HAC,
based on the structure of the alphoidtetO HAC. That first
synthetic HAC was constructed from centromeric DNA with a
dimeric structure.2 One monomer of the alphoidtetO HAC was
derived from the centromere of chromosome 17 type I α-
satellite DNA containing a CENP-B box. The other monomer
was wholly synthetic alphoid DNA and carried a Tet operator
(TetO) in place of the CENP-B box. The CENP-B box is
found on all human chromosomes (except the Y) and is a 17
bp sequence recognized by the protein CENP-B.24,25 This
protein’s function is still under investigation, but CENP-B
binding is required for stable deposition of the centromeric
histone H3-variant CENP-A when HAC-seeding DNA is
introduced into cells.26−29 The presence of the TetO sequence
on the synthetic HAC allows the centromeric DNA to be
targetable with chimeric Tet repressor (TetR)-fusion proteins
that can manipulate the chromatin environment of the
centromere and therefore modify the behavior of the HAC
centromere.
Here, we have performed the first systematic study of
rearrangements that occur during HAC formation and
determined how they alter the epigenetic landscape in the
HAC centromere and how they impact HAC segregation in
mitosis. The seeding DNA of the new alphoid2domain HAC
resembles that used to construct the alphoidhybrid HAC
described earlier4 but was much larger, as we hypothesized
that this might minimize the need for rearrangements and
amplification during HAC formation. The alphoid2domain HAC
contains a CENP-B-containing centrochromatin array and a
non-CENP-B-containing domain. The presence of two differ-
ent domains allows simultaneous targeting of centromeric and
flanking regions with different (TetR, LacI, and Gal4) fusion
proteins and also makes it possible to track rearrangements
within and between the arrays. Using this new alphoid2domain
HAC, we demonstrate that dramatic DNA rearrangements can
occur early during HAC formation and that once formed, they
are stably maintained across many cell generations. Thus, a
time-limited disruptive event of DNA shredding and shuffling,
possibly involving a process resembling chromothripsis,30−32
can occur early during centromere establishment in human
cells.
■ RESULTS
Generation of Synthetic α21-ITetO and α21-IILacO/Gal4
Arrays Using Tandem Ligation Array Amplification. The
alphoid2domain HAC is formed by two arrays, similarly to a
previously constructed alphoidhybrid HAC,4 but using a ∼2.5×
larger (∼120 kb) HAC-seeding construct. The CENP-B-
containing centrochromatin array was designed to resemble
the previously published alphoidtetO HAC,2 but in this case,
using 11-mer (1886 bp) high order repeats (HORs) of alphoid
type I DNA from the centromere in human chromosome 21.
Each monomer of this synthetic HOR contains either a 17 bp
CENP-B box, essential for CENP-A deposition,29,33 or a 39 bp
tetracycline operator (TetO) targetable sequence, which is the
binding site for E. coli tetracycline repressor (TetR). This
dimer is the basic unit for the so-called α21-ITetO (TetO) array,
which consists of alternating CENP-B-containing and TetO
(non-CENP-B)-containing monomers (Figures 1A, S1A).
The other, non-CENP-B-containing, array is comprised of
repeated segments of α-satellite type II DNA, lacking CENP-B
boxes. In endogenous chromosomes these sequences form the
pericentromeric heterochromatin flanking the centromere. To
allow targeting of this non CENP-B-containing array with
different fusion proteins, LacO and Gal4-targetable sequences
were embedded in the array, as previously described.4 This
allows its targeting by chimeric fusions to either E. coli lactose
repressor (LacI) and/or the yeast Gal4 protein. We refer to
this non-CENP-B-containing array as the α21-IILacO/Gal4
(LacOGal4) array (Figure 1A and Figure S1A).
Our initial cloning efforts yielded a α21-ITetO 11-mer (1886
bp) and a α21-IILacO/Gal4 12-mer (2068 bp) in a plasmid
backbone (Figure S1B,C). Each basic unit of this 11-mer or
12-mer was then elongated by tandem-ligation-amplification
until fragments containing 8 copies were obtained (Figure 1B
and Figure S2A). In this tandem-ligation-amplification, cycles
of restriction enzyme digestion were performed and followed
by ligation as shown in Figure S2A. Upon each cycle of
ligation, the restriction site joining the two units was lost, so
the next digestion occurred without cutting the nascent
elongating array. In this case, cycles of SpeI/ScaI and NheI/
ScaI digestions were performed (Figure S2A). After each
round of restriction digestion and ligation, the nascent DNA
was cut with BamHI and NotI, in order to separate the inset
from the 2.9 kb vector, and subsequently analyzed by agarose
gel electrophoresis (Figure 1C). Ultimately, the highest
molecular weight band (16.6 kb for 8 copies, marked with
*) was excised and cloned into a BAC vector capable of more
stably maintaining longer repetitive sequences. The structure
of the BAC vector is shown in Figure S1D.
Starting from a BAC clone carrying 8 copies of the 11-mer
and 12-mer, the tandem-ligation-amplification process was
repeated until the insets reached 32 copies (∼60 kb). To do
that, cycles of SpeI/KasI and NheI/KasI digestions were
performed (Figure S2B). As before, the nascent array was cut
with BamHI and NotI after each reaction of restriction
digestion and ligation to separate the inset from the 7.1 kb
BAC vector and analyzed by agarose gel electrophoresis
(Figure 1D).
Ultimately, the two complete α21-ITetO and α21-IILacO/Gal4
arrays (∼60 kb each) were joined together by tandem ligation
into a pBAC vector containing a G148 resistance gene (Figure
1A,D and Figure S2B). As a result, we obtained the HAC-
seeding construct pBAC11.32TW12.32GLII, carrying 32
copies of the α21-ITetO 11-mer and 32 copies of the α21-
IILacO/Gal4 12-mer, with a total length of ∼120 kb (Figure 1D,
red arrow). This input DNA was then amplified in bacteria
prior to transfection into human HT1080 fibrosarcoma cells
for HAC formation.
Isolation of Input pBAC11.32TW12.32GLII DNA with
Equal Amounts of α21-ITetO and α21-IILacO/Gal4 Repeats.
To amplify the HAC-seeding construct, pBAC11.32TW12.32-
GLII DNA was electroporated into E. coli DH10B and the size
of the array was determined by CHEF (contour-clamped
homogeneous electric field) gel electrophoresis. In all, 16
BACs isolated from different bacterial clones were obtained
from large scale bacterial cultures and digested with NotI and
BamHI to release the HAC-seeding array from the BAC
backbone (Figure 2A, B). Gel electrophoresis revealed that 8
out of 16 colonies (labeled in red in Figure 2A) maintained the
original ∼120 kb length of the synthetic BAC DNA (Figure
2A, red arrow).
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Figure 3. Screening of HT1080 colonies after transfection with pBAC11.32TW12.32GLII. (A) Scheme showing the possible fates of the
pBAC11.32TW12.32GLII HAC seeding DNA after transfection in HT1080: in yellow and green (as integration or HAC) is represented the
synthetic DNA. Timeline of the experiments performed from transfection into HT1080 cells. (B) BAC copy number (y axis) analyzed by qPCR in
each HT1080 clone (x axis): only HT1080 clones containing >20 BAC copies are represented in the graph. HT1080 clones are represented in
green (HAC), red (integration), or mixture (both) according to the results of the FISH screening, as shown in C. Black arrows indicate the clones
shown in C and analyzed further. (C) Representative pictures of oligo-FISH staining of HT1080 clones: slides have been hybridized with DNA
probes (TetO-dig/rhodamine α-dig antibody, Gal4-biotin and LacO-biotin/Fitc-streptavidin). DAPI stains DNA. Scale bar = 10 μm. (D) Southern
blot of selected HT1080 clonal DNA (as labeled on top of the panel) digested with BamHI and separated by CHEF; the transferred membrane was
hybridized with radioactively labeled TetO (left) or LacO (right) specific probes. Red arrows indicate the expected size of the band without
rearrangements. Clones labeled in red have been screened further (M and m, markers). (E) Cartoon of the pBAC11.32TW12.32GLII input DNA
showing restriction sites for NotI and BamHI.
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To establish a HAC with an equal amount of CENP-B-
containing and non-CENP-B-containing chromatin, it was
impo r t a n t t o confi rm th a t t h e HAC- s e ed i n g
pBAC11.32TW12.32GLII DNA carries an equal number of
α21-ITetO and α21-IILacO/Gal4 arrays. To do so, we digested the
input DNA with EcoRI, a restriction enzyme that cuts both the
arrays and the BAC vector (Figure S1B,C,D; only single-cut
restriction enzymes are shown). We predicted in silico how the
EcoRI restriction pattern should look (Figure S1E) and
whether each band originates from the α21-ITetO or the α21-
IILacO/Gal4 array. The α21-ITetO array cut with EcoRI should
produce a fragment of 1880 bp, while the α21-IILacO/Gal4 array
should produce fragments of 677, 370, 342, 340, and 339 bp.
The vector yields a band of 7499 bp (Figure S1E).
The 8 colonies containing ∼120 kb BAC DNA were
digested with EcoRI and the corresponding digests run on an
agarose gel (Figure 2C). The results in Figure 2C match the
prediction in Figure S1E. Analyzing the intensity of the
corresponding bands on the agarose gel in Figure 2C using
ImageJ, we scored the ratio between α21-ITetO and α21-
IILacO/Gal4 arrays. This confirmed that the BAC DNA contains
equal amounts of α21-ITetO and α21-IILacO/Gal4 repeats (Figure
2D). Thus, BAC DNA from clone number 1 (number 1 of
Figure 2A and 2C; Figure 2E, sample in duplicate) was chosen
as our HAC-seeding input DNA for HAC formation in human
cells.
Screening of HT1080 Colonies Following Trans-
fection with HAC-Seeding DNA. HAC formation occurs
following transfection of the HAC-seeding DNA into a suitable
cell line, and colonies originating from single cells grow under
selection. During the process, the input DNA is incorporated
into the cell nucleus where it can undergo different fates: it can
be integrated into a chromosome arm; it can form an
autonomous HAC; the cell population can contain a mixture
of both (Figure 3A); or, less frequently, the cells can acquire
drug resistance but lose the remainder of the input DNA (not
shown).34 In order to form a HAC, the input DNA must
multimerize to reach a threshold size for a stable
chromosome.23 This step occurs naturally after transfection
and it is uncontrollable, leading to different levels of
amplification of the input DNA within the cell. As a result,
after transfection each single colony contains either a HAC, an
integration, or a mixture of the two, with a different degree of
amplification of the HAC-seeding DNA.34
As previously published,2,4 we chose to transfect
pBAC11.32TW12.32GLII into HT1080 cells. This fibrosarco-
ma cell line has a chromatin state permissive for HAC
formation due to having a relatively low level of H3K9me3 as a
result of decreased expression of Suv39h1 methyltransferase.10
In cells with higher Suv39h1 expression, CENP-A assembles
on HAC-seeding DNA, but is subsequently displaced by
invading H3K9me3-containing heterochromatin.10
pBAC11.32TW12.32GLII from clone 1 (Figure 2E) was
transfected into HT1080 cells and single cell clones were
grown for 3 weeks in media containing Geneticin. We collected
genomic DNA from 124 resistant colonies and measured the
BAC copy number by qPCR to obtain an approximate
measurement of the degree of amplification of HAC-seeding
DNA. Primers specific for the alphoid2domain HAC were
designed and a different HAC with a known BAC copy
number was used as standard.
Thirty HT1080 colonies containing detectable amounts of
HAC-seeding BAC sequences (copy numbers >20), were then
screened by fluorescent in situ hybridization (FISH) for the
presence of HACs, integrations, or mixtures of both (Figure
3B). FISH to detect pBAC11.32TW12.32GLII was performed
4 weeks after transfection (timeline in Figure 3) using TetO
and LacO-specific oligos labeled with fluorochromes (see
Methods for details). Figure 3B presents data of the qPCR
analysis combined with the results of the FISH screening.
Representative images from the FISH screening of selected
HT1080 clones are shown in Figure 3C. HACs can be
visualized as discrete spots by DAPI staining (Figure 3C).
Interestingly, the size of each HAC estimated by FISH
correlated the results of qPCR, with the larger HACs
corresponding to higher BAC copy numbers and vice versa
(Figure 3B black arrows, C). For simplicity, we discarded
HAC-containing clones with more than 1 HAC.
In all HACs, the α21-ITetO array seems to localize to the
center of the HAC, where it is surrounded by the α21-
IILacO/Gal4 arrays (Figure 3C). This organization corresponds to
that seen for previously published HACs,4 and presumably
reflects the HAC structure, with a CENP-B-containing
centromere surrounded by pericentromeric heterochromatin.
pBAC11.32TW12.32GLII Forms HACs More Efficiently
than Previous HAC-Seeding Constructs. In order to
determine the fate of the HAC-seeding DNA, a minimum of
25 metaphases were screened by FISH for each clone. In the
screening shown in Figure 3B, 30% (9/30) of HT1080
colonies contained only HACs, 43% (13/30) contained
integrations, and 26.6% (8/30) contained a mixture of both.
This frequency of HAC-containing colonies for the
alphoid2domain HAC is ∼3 times higher than in previous
studies.2,4,33 The relationship between the size of the HAC-
seeding DNA and the efficiency of HAC formation is complex
and may be influenced by the actual HAC-seeding sequences
employed. Synthetic sequences seem to yield a lower efficiency
of HAC formation than natural alphoid sequences. Examina-
tion of the literature reveals that the efficiency of HAC
formation varies greatly depending on the type of alphoid
centromeric DNA used for transfection (e.g., 32% HAC-
forming colonies using DNA from chromosome 17 centro-
mere, and only 4.3% of positive colonies using DNA from Y
chromosome).35 Ebersole and colleagues obtained a 10%
efficiency of HAC colony formation using a ∼120 kb 5mer-
based synthetic array.33 In contrast the transfection with a
∼120 kb alphoidtetO HAC-seeding DNA array yielded an
efficiency of HAC formation of 4.3%.2 In contrast, we observed
an 11.7% efficiency of alphoidhybrid HAC formation using the
much smaller ∼60 kb synthetic DNA.4 In the present study,
the efficiency of HAC formation by pBAC11.32TW12.32GLII
(30%) was comparable to the frequency of HAC formation
reported in our previous study when cells were stably
cotransfected with the HAC seeding DNA plus CENP-A
directed to the synthetic centromere.4 It is possible that a
combination of the structure and the size of the alphoid2domain
HAC DNA may increase the efficiency of CENP-A deposition
on the centromeric DNA, although other factors cannot be
ruled out.
A n a l y s i s o f R e a r r a n g em e n t s o f t h e
pBAC11.32TW12.32GLII Arrays in HAC-Containing
HT1080 Colonies. We wished to determine whether the
size amplification that occurred during early stages of
alphoid2domain HAC formation was also accompanied by
rearrangements of the HAC-seeding DNA arrays. To perform
a structural analysis of the α21-ITetO and α21-IILacO/Gal4 arrays,
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we performed Southern blot analysis using TetO and LacO
specific probes (Figure 3D). Cell clones were grown for 8
weeks, or approximately 50 doublings of the HT1080 cells,
prior to Southern blot analysis (timeline in Figure 3). Genomic
DNA from 9 HAC-containing cell lines (and two HT1080
clones containing integrations as control) was digested with
Figure 4. Analysis of rearrangements of the pBAC11.32TW12.32GLII arrays. Timeline of the experiments performed from transfection into
HT1080 clones and subclones. (A,B,C) Southern blot of subclones from clone E30 (A), J34 (B) and E16 (C): DNA was digested with BamHI and
separated by CHEF. The transferred membrane was hybridized with radioactively labeled TetO (left) or LacO (right) specific probes. Cartoons on
the right represent the outcome of rearrangements in the corresponding clone: green arrows represent α21-ITetO array, yellow arrows represent α21-
IILacO/Gal4 array, boxes represent the BAC vector (M and m, markers).
ACS Synthetic Biology pubs.acs.org/synthbio Research Article
https://dx.doi.org/10.1021/acssynbio.0c00326
ACS Synth. Biol. 2020, 9, 3267−3287
3273
BamHI, which has a unique site only on the vector backbone
(Figure 3E). The DNA fragments were separated by CHEF gel
electrophoresis and the membranes hybridized with TetO and
LacO-specific probes.
If only simple multimerization of pBAC11.32TW12.32GLII
occurred during HAC formation, the Southern blots should
display a single ∼120 kb band, corresponding to the size of
digested input DNA. Importantly, since the restriction enzyme
cuts only at the edge of the α-satellite arrays, this should be the
case regardless of whether the Southern blot analysis uses the
TetO or LacO probe. Surprisingly, none of the analyzed clones
showed this single ∼120 kb band (Figure 3D, red arrow).
Instead, each clone has a different number of DNA fragments
of different sizes, and these also vary for each clone for the two
probes. Many bands are smaller than the 120 kb input band,
but some are considerably larger. Thus, the arrays of the HAC-
seeding pBAC11.32TW12.32GLII DNA underwent a complex
series of rearrangements during HAC formation, as described
for the alphoidtetO HAC.3
On the basis of the results displayed in Figure 3, we decided
to further characterize three clones (E30, J34 and E16) that
showed different levels of amplification by qPCR (black arrows
in Figure 3B) and different numbers and sizes of rearrange-
ments by Southern blotting (labeled in red in Figure 3D).
pBAC11.32TW12.32GLII Undergoes Multiple Rear-
rangements during Early Stages of HAC Formation.
The rearrangement of HAC-seeding DNA was previously
described for the single-domain alphoidtetO HAC.3 It was
proposed that the HAC-seeding DNA structure may continue
to change and evolve for weeks or possibly months after HAC
transfection. This raises the possibility that the populations
analyzed in Figure 3D might consist of mixtures of
alphoid2domain HACs with different structures. To test this
hypothesis, the three clones E30, J34 and E16 were further
subcloned to obtain homogeneous cell populations (timeline
in Figure 4; 9 weeks or approximately 55 population doublings
after transfection). Initially clone E21 was also subcloned but,
unfortunately, we could not grow any subclone with stable
HAC segregation, so E21 was excluded from the subsequent
analysis.
Alphoid2domain HAC subclones were isolated by limiting
dilution and screened by FISH for the presence and the
number of the HACs in each clonal cell line (12 subclones for
E30, 35 subclones for J34 and 25 subclones for E16; detailed
timeline in Figure S3). Subclones with highly mis-segregating
HACs were discarded and subclones with a higher percentage
of single HACs per cell were studied further (6 subclones for
E30, 8 subclones for J34 and 10 subclones for E16; Figure 4).
As an example of the screening, Figure S3A shows
representative images from FISH screening of 6 subclones
from clone E30. Figure S3B shows the number of metaphases
containing 0, 1, or 2 HACs in subclones from clone E30, with
percentages indicating the cells with 1 HAC.
To study rearrangements in subsequent cell generations,
genomic DNA from the selected subclones originating from
E30, J34 and E16 was digested with BamHI and separated by
CHEF gel electrophoresis (Figure 4). Surprisingly, Southern
blot analysis revealed that all subclones were almost identical
in the number and sizes of rearrangements. Furthermore, they
all recapitulated the pattern of rearrangements seen in the
original clone (Figure 4A−C). As for the original clones,
hybridization with the TetO-specific probe consistently yielded
a different hybridization pattern from that seen with the LacO-
specific probe on the same sample.
To strengthen our hypothesis that the HAC-seeding DNA
undergoes a series of multiple rearrangements, we decided to
investigate the structure of the alphoid2domain HAC using FISH
on DNA fibers (Figure S4). We hybridized stretched DNA
from clone E30 (subclone 1B5), clone J34 (subclone 1.10) and
clone E16 (subclone 23) with TetO and LacOGal4 specific
probes. Images reveal that there is not a regular alternation of
TetO and LacOGal4 spots on DNA fibers, as we would expect
if the alternating TetO/LacO structure of the HAC-seeding
DNA had been maintained. Instead, TetO and LacOGal4 spots
on DNA fibers show various size and patterns, confirming that
rearrangements occur during HAC formation (Figure S4).
Taken together, these data show that the α21-ITetO and α21-
IILacO/Gal4 arrays of HAC-seeding DNA pBAC11.32TW12.32-
GLII independently undergo unique fragmentation, recombi-
nation and amplification events during the first 8 weeks of the
alphoid2domain HAC formation. Subsequently, these rearrange-
ments appear to be maintained stably through cell generations,
up to 14 weeks. This agrees with the observation that the HAC
structure seems to be stable through multiple cycles of MMCT
(microcell mediated chromosome transfer) in different cell
lines.3,36
Different HAC-Containing Clones Show Different
Degrees of Rearrangements. Not all the alphoid2domain
HAC clones analyzed underwent the same degrees of
rearrangements. For example, subclones from clone E30
(Figure 4A) display a predominant band around 50 kb in all
subclones, and only 2 of the 6 subclones clearly show
fragments around 80−100 kb with both probes (subclones 4B5
and 4D8). In contrast, the LacO probe shows 3−4 bands with
various signal strengths. This could reflect dimerization/
multimerization of the 50 kb fragment observed in the blot.
Thus, compared with the other clones analyzed, E30 seems to
be less scrambled, with all fragments showing the same size
(cartoon in Figure 4A). It therefore appears that during E30
HAC formation pBAC11.32TW12.32GLII underwent an early
event in which both the α21-ITetO and α21-IILacO/Gal4 arrays
were shortened to roughly 40% of their initial lengths (easiest
to imagine if a single deletion of the 120 kb construct occurred
spanning the junction between the two arrays), but then were
amplified while avoiding further rearrangements.
In marked contrast, clones J34 and E16 displayed a much
larger number and variety of rearrangements, with fragments
ranging from ∼50 kb up to ∼300 kb (Figure 4B, C and relative
diagrams on the right). One possible explanation for this
structure is that early during formation of those two HACs and
following some initial amplification of the arrays, the nascent
HAC-seeding DNA experienced multiple chromosome breaks
and shuffling followed by religation, leading to fragments of
different sizes.
Interestingly, the smaller array size in clone E30 (Figure 4A)
correlates with its larger number of BAC copies (presumably
resulting from a larger number of amplification cycles)
quantitated by qPCR (Figure 3B). In contrast, J34 and E16
with more complex rearrangements, including those producing
much larger fragments (Figure 4B,C), have lower BAC copy
numbers (Figure 3B). These observations suggest that the
rearrangements may have occurred very early, prior to
completion of the multimerization that allowed the HAC to
pass the minimum size threshold required to form a stable
centromere/kinetochore.23
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These data show that, as previously suggested,3 during
alphoid2domain HAC formation, the predicted regular structure
of the HAC-seeding DNA is disrupted by complex rearrange-
ments whose mechanism remains unknown.
Visualization of α21-ITetO and α21-IILacO/Gal4 Arrays on
Chromatin Fibers. We performed indirect immunofluor-
escence (IF) staining on stretched DNA fibers to confirm the
presence of α21-ITetO and α21-IILacO/Gal4 arrays, and to also
determine the distribution of CENP-A and H3K9me3 on those
fibers.
For each set of subclones, one was selected for further
experiments, based on the percentage of cells bearing a single
HAC (E30 subclone 1B5, J34 subclone 1.10 and E16 subclone
23; as example for clone E30, see Figure S3B). DNA fibers
were prepared from the selected subclones and incubated with
purified TetR-eYFP or LacI-eYFP fusion proteins expressed in
E. coli to visualize the corresponding array (TetR-eYFP and
LacI-eYFP expressed in vivo, both dissociate from the
chromatin during fiber preparation) (Figure 5A and Figure
S6). Staining of both arrays simultaneously was not possible,
since the purified proteins were both tagged with GFP.
Attempts to specifically stain fibers with mCherry-TetR
isolated from E. coli were not successful. Fibers were also
stained using CENP-A or H3K9me3-specific antibodies
(Figure 5A).
IF staining on fibers revealed that the α21-ITetO and α21-
IILacO/Gal4 arrays are both present along these stretched DNA
fibers. CENP-A and H3K9me3 are adjacent to both arrays,
with no apparent preference for one or the other array
(representative images for J34 subclone 1.10 are shown in
Figure 5A). The presence of CENP-A and H3K9me3 in close
proximity to both arrays can be explained if the rearrangements
during alphoid2domain HAC formation lead to a “scrambled”
structure of the α21-ITetO and α21-IILacO/Gal4 arrays.
Geneticin Selection Enriches the Number of HACs in
the Cell Population. To characterize how the mitotic
stability of the alphoid2domain HAC is affected by its structure,
we performed a stability assay, counting the number of cells
with different number of HACs over a period of 30 days with
(+) and without (−) Geneticin (∼25 cell divisions).
Metaphase chromosome spreads from E30 subclone 1B5, J34
subclone 1.10 and E16 subclone 23 were analyzed by FISH
and imaged at each time point using labeled oligos specific for
Figure 5. Visualization of α21-ITetO and α21-IILacO/Gal4 arrays on chromatin fibers and mitotic stability of the HAC. (A) Representative pictures of
IF staining on fibers of subclone J34 1.10: slides have been incubated with TetR-eYFP and LacI-eYFP expressed in E. coli and stained with α-
CENP-A mouse or α-H3K9me3 mouse/TRITC α-mouse antibody. DAPI stains the DNA. Scale bar = 5 μm. (B) Number of metaphases (%)
containing 0, 1, or ≥2 (2 or 3) HACs for subclones E30 1B5, J34 1.10 and E16 23, after spreading metaphases and hybridizing with TetO and
LacO/Gal4 specific probes; total of 2 biological repeats, 50 metaphases for each condition were analyzed. ± Gen indicates treatment for 30 days
from day 0 with (+) or without (−) Geneticin. Error bars denote SEM. Statistical test: unpaired t test (*P < 0.05, **P < 0.01).
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α21-ITetO and α21-IILacO/Gal4, to count cells containing 0, 1, or
≥2 HACs.
At time point zero, each subclone had a characteristic
number of cells with 0, 1, or ≥2 HACs (Figure 5B).
Figure 6. CENP-A accumulates preferentially on the α21-ITetO array. (A,B,C) ChIP-qPCR analysis of CENP-A and indicated histone marks
modifications in HT1080 subclones E30 1B5 (A), J34 1.10 (B), and E16 23 (C). The α21-ITetO array (TetO), α21-IILacO/Gal4 array (LacOGal4),
satellite D17Z1 (chr17), and degenerate satellite II (sat2) repeats were assessed. Values have been normalized against satellite D17Z1 (chr17).
Total of 2 biological repeats, n ≈ 5 × 106 cells each. Error bars denote SEM. Statistical test: Mann−Whitney test (*P < 0.05). (D) Cartoon showing
the localization of primers used in qPCR on the HAC and on endogenous corresponding chromosomes.
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Interestingly, 7 days after thawing and while growing in the
presence of Geneticin (corresponding to time point zero), the
number of cells containing no HAC was higher than expected
(20−40% of the cell population, gray bars) for all three
Figure 7. α21-ITetO and α21-IILacO/Gal4 arrays are not functionally independent. (A,B) Quantification of HAC-associated CENP-A staining (A) and
H3K9me3 staining (B) in individual cells of each indicated HT1080 subclone 48 h after transfection with the indicated fusion proteins; values
plotted as A.F.U. (arbitrary forming units). Solid bars indicate the medians, and error bars represent the SD; n = two independent experiments for
each staining; ∼30 cells analyzed in each experiment. Asterisks indicate a significant difference (*P < 0.05, **P < 0.01, ***P < 0.001, ****P <
0.0001; Mann−Whitney test). (C) Number of interphase nuclei (%) showing correct segregation (1 HAC) or mis-segregation (0 or 2 HACs) of
each indicated HT1080 subclone 48 h after transfection with the indicated fusion proteins; the presence of the HAC was detected by GFP signal. n
= 500 cells analyzed per condition (****P < 0.001; Fisher’s exact test).
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subclones. It is possible that after the stress of freezing/
thawing, cells were not yet fully responding to the selection.
Importantly, all of the alphoid2domain HACs are extremely
stable after 30 days growth in the absence of Geneticin, as
shown by the number of cells bearing 1 HAC (black bars; daily
loss rate of the HAC (R) = 4.76 (±0.6) × 10−3 for E30
subclone 1B5; 8.69 (±6.67) × 10−3 for J34 subclone 1.10; and
3.47 (±1.66) × 10−3 for E16 subclone 23; see Methods).
These measured loss rates were comparable to those measured
for previous HACs.2,4 Thus, alphoid2domain HACs with
dramatically different rearrangements of their seeding DNA
are very similar in their ability to replicate and segregate
correctly during the great majority of cell divisions.
Surprisingly, when cells grow for 30 days (+) Geneticin, they
seem to acquire a selective advantage for increasing the HAC
copy number, as shown by the number of cells bearing ≥2
HACs (white bars). The accumulation of HAC was
particularly evident in J34 subclone 1.10 and E16 subclone
23, while E30 subclone 1B5 did not exhibit this increase
(Figure 5B). Notably, the enrichment of cells with 1 or ≥2
HACs after 30 days (+) Geneticin was coupled for all
subclones with a reduction in the number of cells with 0
HACs.
The enrichment in cells with ≥2 HACs could be explained if
heterochromatin spreading silences the Geneticin resistance
gene. In this case, Geneticin would select for cells in the
population with an increased HAC copy number. Despite the
small sample size, it is interesting to note that the alphoid2domain
HACs with the more rearranged arrays (J34 1.10 and E16 23)
were those where the copy number increased under selection,
possibly indicating that the chromatin state is less stable. In
contrast, the clone with the least rearranged structure (E30
1B5) showed the highest chromatin stability. Taken together
these data suggest that the HAC DNA structure may have an
impact on HAC chromatin stability over time.
CENP-A Accumulates Preferentially on the α21-ITetO
Array with CENP-B Boxes. The IF staining on fibers in
Figure 5 shows CENP-A and H3K9me3 apparently localized
on both the α21-ITetO and α21-IILacO/Gal4 arrays. To better
characterize the chromatin state of the two arrays on the HAC-
seeding DNA, we performed chromatin immunoprecipitation
(ChIP) for CENP-A and several indicative histone modifica-
tions using a set of well-characterized monoclonal antibodies,37
followed by quantitative PCR (ChIP-qPCR) on genomic DNA
from E30 subclone 1B5, J34 subclone 1.10 and E16 subclone
23 (scheme of the primers used for qPCR is presented in
Figure 6D).
ChIP data were highly reproducible for the three subclones
of the alphoid2domain HAC (Figure 6A,B,C). Thus, the overall
chromatin organization was maintained despite differences in
the level of rearrangements. CENP-A accumulated on the α21-
ITetO array ∼2−3 times more than on the α21-IILacO/Gal4 array
in all the three subclones. This is an average of ∼1.5 times
more than on the endogenous centromere of chromosome 17,
used as a control (Figure 6A,B,C). This contrasts with a
previous study in which the alphoidhybrid HAC was apparently
unable to maintain CENP-A only on the centromeric array.4 It
is possible that CENP-A deposition on the α21-ITetO array may
be favored by the larger size of the input pBAC11.32TW12.32-
GLII HAC-seeding DNA. CENP-A deposition also correlated
with higher levels of H3K4me2 and H3K36me2, as expected
for centrochromatin.7,9 The α21-ITetO array also contained a
relatively high level of H3K9me3 and a low level of H3K9ac
(Figure 6A,B,C), revealing differences from the alphoidtetO
HAC, which contained a single HAC-seeding array.2,7
Unexpectedly, the α21-IILacO/Gal4 array had levels of H3K9ac
and H3K4me2 (markers for actively transcribed chromatin) ∼
twice those of the satellite II DNA used as a control.
Consistent with this observation, levels of H3K9me3 on the
α21-IILacO/Gal4 array were ∼2−4 times lower than on the α21-
ITetO array (Figure 6A,B,C), revealing a generally open
conformation of the chromatin. This was surprising, as we
had initially expected this array, which lacks CENP-B boxes, to
form heterochromatin. Our data suggest that a regular array of
alphoid type II DNA lacking CENP-B boxes is not sufficient to
establish pericentric heterochromatin. However, given the
intermixing of sequences on the HAC-seeding DNA, we
cannot exclude the possibility that the presence of strong
heterochromatin might have been counter-selected due to its
potentially harmful effects on expression of the Geneticin-
resistance gene or to the juxtaposition with large numbers of
CENP-B boxes.
Taken together these data suggest that α21-ITetO array
recruits CENP-A and establishes a functional centromere in
the alphoid2domain HAC, despite sustaining high levels of
H3K9me3.
α21-ITetO and α21-IILacO/Gal4 Arrays Do Not Form
Functionally Independent Chromatin Domains. To
determine whether the molecular structure of the HAC
impacts the function of the α21-ITetO and α21-IILacO/Gal4
arrays, we asked whether the two arrays are functionally
distinct. To do this, we transiently expressed KAP1 as a
chimeric fusion to either TetR-eYFP or LacI-GFP. KAP1 is a
scaffolding protein that recruits the CoREST complex,
promoting a silent chromatin state and increasing the level
of H3K9me3.38 Previous studies revealed that KAP1 recruit-
ment into the centromere causes a loss of CENP-A and
inactivates the kinetochore.39 Thus, if the two arrays on the
alphoid2domain HAC are functionally independent, KAP1
recruitment should have an effect of the HAC centromere
only when targeted to the α21-ITetO array.
We performed quantitative fluorescent analysis to measure
the level of CENP-A and H3K9me3 on the alphoid2domain HAC
after targeting KAP1-eYFP fusions to the two arrays both
separately and simultaneously for 48 h, using the eYFP to
localize the HAC arrays in interphase cells (Figure S5A,B).
Targeting KAP1 to the α21-ITetO array led to a significant (∼2
fold) decrease in CENP-A levels on the HAC for all three
subclones analyzed (Figure 7A). This is similar to what was
reported for the alphoidtetO HAC6. The decrease in CENP-A
was accompanied by an increase in H3K9me3 levels when
targeting KAP1 to the α21-ITetO array (Figure 7B). Different
subclones showed different levels of H3K9me3 enrichment,
possibly due to intrinsic variation in the H3K9me3 basal levels
in each subclone (Figure 6A,B,C).
Targeting KAP1 to the α21-IILacO/Gal4 array also resulted in a
decrease in HAC-associated CENP-A, although the effect was
milder than observed with tethering to the α21-ITetO array
(Figure 7A). Thus, even though most CENP-A was associated
with the α21-ITetO region, targeting proteins to the α21-
IILacO/Gal4 region still affected CENP-A levels. This confirms
the proximity of the arrays and is consistent with the pattern of
histone modifications observed in Figure 5A. The increase in
H3K9me3 levels seen after tethering KAP1 to α21-IILacO/Gal4
array appeared to be more significant than tethering KAP1 to
α21-ITetO. This could be explained by the initial lower level of
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H3K9me3 on the α21-IILacO/Gal4 array (Figure 6A,B,C): there
might be more unmodified H3K9 that can be converted to
H3K9me3 upon the effect of KAP1.
Targeting KAP1 to both arrays simultaneously did not
completely suppress kinetochore function as revealed by
CENP-A levels, which are partly maintained. In the double
tethering, neither CENP-A nor H3K9me3 levels differed
greatly from the single tethering, rejecting the hypothesis that
the arrays are independent and they would cooperate to
establish a state of “super-repression” when both targeted with
KAP1 (Figure 7A,B).
In parallel with measuring the effects of KAP1 tethering on
CENP-A and H3K9me3 levels, we also scored the effects of
this tethering on centromere function (e.g., HAC segregation in
mitosis). Despite differences in levels of correctly or mis-
segregating HACs in the initial cell populations, targeting
KAP1 to one or both arrays always led to a significant increase
in the number of mis-segregating HACs. Interestingly,
segregation was significantly impaired even when overall
Figure 8. Early stages of alphoid2domain HAC formation. (A) Scheme representing how HAC-seeding DNA rearranges to form the alphoid2domain
HAC. HAC-seeding DNA formed by α21-ITetO (green) and α21-IILacO/Gal4 (yellow) arrays is transfected in HT1080 cells; under the effect of
proteins of the DNA-sensing pathways (elements in red and blue), the nascent HAC gets initially rearranges and it increases in size due to
“slippage” during replication (dashed arrow indicates nascent HAC entering the nucleus). During mitosis, the nascent HAC lags and it gets
therefore incorporated into a micronucleus, resulting in additional massive rearrangements which lead to the final structure of the alphoid2domain
HAC. (B) Indirect immunofluorescence of HT1080 cells constitutively expressing TetR-EYFP at indicated time points after transfection with
HAC-seeding DNA. After fixation, cells were stained for CENP-A; DAPI stains the nuclei. Enlargements show nanonuclei containing HACs (green
bright spots). Scale bar = 10 μm.
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CENP-A levels were not greatly reduced by KAP1 (Figure
7C). This is probably because the percentage of mis-
segregating cells is determined by scoring individual cells in
which the level of CENP-A falls below a critical threshold, and
it is not determined by the average CENP-A level in the cell
population, as already described.40
Together, these observations lead to the conclusion that
CENP-A, H3K4me2 and H3K36me2, which are all necessary
for kinetochore maintenance and function, are enriched on the
α21-ITetO array in the alphoid2domain HAC. Nevertheless, the
close proximity and scrambled structure of the two arrays
allows the chromatin modifier KAP1 to act simultaneously on
both arrays.
■ DISCUSSION
We have generated several alphoid2domain HACs by transfecting
HT1080 cells with pBAC11.32TW12.32GLII, a HAC-seeding
DNA of ∼120 kb. This HAC-seeding DNA contains two
distinct α-satellite DNA arrays: one rich in binding sites for
TetR and CENP-B and one lacking CENP-B boxes but having
binding sites for LacI and Gal4. We had expected that the
former might form centrochromatin and the latter hetero-
chromatin, but experimental results revealed another outcome.
The new alphoid2domain HAC shows two important differ-
ences from previous generations of synthetic HACs
(alphoidtetO HAC and alphoidhybrid HAC).2,4 First, the
efficiency of alphoid2domain HAC formation in HT1080 was
higher than that typically seen with other HACs.2,4 Indeed, it
was comparable to results obtained when cotransfecting the
HAC-seeding DNA plus CENP-A specifically targeted to the
synthetic centromere.4 It therefore appears that this longer
HAC-seeding DNA may be more efficient at promoting stable
CENP-A deposition. Second, ChIP-qPCR analysis revealed
that CENP-A accumulated preferentially on the CENP-B-
containing array of the alphoid2domain HAC. This was not
observed with the previous alphoidhybrid HAC, which was
formed from a smaller HAC-seeding DNA.4
Surprisingly, H3K9me3 was also recruited to the CENP-B-
containing array on the alphoid2domain HAC. Previous results
have revealed that CENP-B can have a dual role in recruiting
centrochromatin or heterochromatin markers depending on
the context.10,27,41 We speculate that the alphoid2domain HAC
shows 3 types of chromatin. Some of the CENP-B-rich arrays
form classical centrochromatin42 containing CENP-A,
H3K4me2 and H3K36me2, but others form H3K9me3-rich
heterochromatin, which previous studies have shown to be
incompatible with centrochromatin. Thus, CENP-A-containing
arrays are likely interspersed with H3K9me3-bearing arrays.
Surprisingly, the non-CENP-B array did not form the predicted
heterochromatin, but instead appeared to form relatively
“open” euchromatin. It is possible that heterochromatin failed
to form as a result of selective pressure to avoid silencing the
Geneticin resistance gene. Following DNA rearrangements,
TetO, LacOGal4 regions and the Geneticin resistance gene can
end up being near one another, potentially selecting against
rearrangements in which heterochromatin forms and spreads
inactivating Geneticin resistance gene. Another possibility is
that the rearrangements bring relatively high levels of CENP-B
boxes close to the alphoid type II DNA, and this somehow
interferes with the ability of the latter to nucleate
heterochromatin.41,43
Studies of the alphoidtetO HAC revealed that HAC-seeding
DNA can undergo dramatic reorganization during HAC
establishment.3 However, the timing and the causes of this
phenomenon were unknown. Our Southern blot analysis of
various clones of alphoid2domain HAC-bearing HT1080 cells
reveals that the HAC-seeding DNA in each clone has
undergone a unique pattern of rearrangements, both in the
size and in the number of fragments observed after restriction
digestion and probing for the arrays present in
pBAC11.32TW12.32GLII. This highly cell-specific pattern is
acquired by each cell in the first 8 weeks following transfection
with the HAC-seeding DNA, apparently before completion of
the multimerization/amplification that allows the transfected
DNA to surpass the size threshold required for stable
segregation in mitosis.23 The specific pattern of rearrange-
ments is stably inherited by HAC-containing subclones, as
shown by Southern blot analysis performed 14 weeks after
HAC seeding DNA transfection and in agreement with
previous reports of HAC stability during MMCT (microcell
mediated cell transfer).3,36 These observations indicate that
early during the process of centromere formation, the HAC-
seeding DNA encounters a limited series of events that lead to
deletions, additions and shuffling of its arrays, but that
subsequent to centromere formation the HAC genome is
stabilized. Importantly, the larger size of the seeding DNA did
not prevent the final structure of the HAC from being
amplified or rearranged, as hypothesized prior to this study.
We propose three discrete steps at which modifications on
the HAC-seeding DNA possibly occur: in the cytosol, shortly
after entry of the HAC-seeding DNA (first step), in the
nucleus during replication (second step), and as a consequence
of micronucleus formation (third step) (Figure 8A). Not every
HAC-seeding DNA will necessarily undergo all three steps, but
we suggest that they can all cooperate to form the rearranged
mature HAC.
It has been reported extensively in the literature that
exogenous DNA is naturally altered upon transfection into
cells. Transfected exogenous DNA can undergo mutations,
deletions, formation of concatemers, or be eventually lost prior
to entering the nucleus.44−49 Most of these modifications
happen early after transfection, before the transfected DNA
replicates.50 This is the result of DNA-sensing pathways:51 for
example, the DNA sensor cGAS binds cytosolic DNA and
produces the second messenger cGAMP, which binds STING
and leads to activation of an inflammatory response.52−54
Indeed, it was recently reported that cGAS has an affinity for
α-satellite DNA.55 Transfected DNA can also undergo double
strand breaks (DSBs) triggering a DNA damage repair
response46 that can involve non-homologous end joining
(NHEJ) or homologous recombination (HR).
We suggest that transfected HAC-seeding DNA activates
these cytosolic responses and that this results in an initial
round of DNA alterations (first step in our proposed model).
This rearranged DNA then enters the nucleus where it
undergoes a process of amplification either due to recombi-
nation or “slippage” during replication due to its repetitive
sequence, leading to the formation of concatemers (second
step). If, during these early stages the HAC-seeding DNA fails
to reach a length sufficient to establish a functional centromere
or accurate regulation of sister chromatid cohesion, then at the
subsequent mitosis the nascent HAC would fail to segregate
properly, likely ending up as a lagging chromosome in
anaphase. Such lagging chromosomes typically lead to
chromosome bridges and micronucleus formation.32,56,57
Both outcomes have been associated with chromothripsis, a
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disruptive event of shredding and shuffling of the DNA, that is
associated with cancer development.30−32,58 During chromo-
thripsis, a region of the genome is cut in tens to hundreds of
pieces by an as-yet unknown agent (although rupture of the
nuclear envelope in micronuclei has been reported to lead to
cGAS accumulation59), and the fragments are rejoined
randomly by NHEJ, generating a patchwork of DNA
fragments.30
If the alphoid2domain HAC-seeding DNA undergoes chromo-
thripsis, large numbers of rearrangements could potentially
occur in a very short period of time (third step). If the
rearranged HAC subsequently attains the minimum size for
stable mitotic segregation, this could explain the origin of sister
HAC-containing cell lines, each with a unique set of
rearrangements. In an effort to investigate early stages of
HAC formation, we decided to follow by microscopy the
HAC-seeding DNA shortly after transfection. Images obtained
at 24, 48, and 96 h after transfection in two different cell lines
(HT1080 and HT1080 constitutively expressing TetR-
EYFP41) show that the forming alphoid2domain HAC can be
found in small micronucleus-like structures termed nanonuclei
that were previously observed when the centromere of the
alphoidtetO HAC was inactivated by altering its epigenetic
status2 (Figure 8B; more images in Figure S7). Those
nanonuclei were postulated to be micronuclei containing a
single HAC formed when the HAC failed to segregate properly
in mitosis. Nanonuclei are negative for CENP-A staining: in
the prior study because the centromere had been inactivated
and here because the centromere has not yet been established
(Figure 8B; more images in Figure S7). The present results are
consistent with a previous report that CENP-A accumulates on
nascent HACs from 4 days after transfection.29 This experi-
ment is consistent with our proposed model.
This model suggests that the fate of the HAC seeding-DNA
may depend on the phase in the cell cycle when transfection
happens, as this could result in a longer or shorter exposure of
the DNA molecule to cytosol. Furthermore, NHEJ is more
active during the G1 phase of the cell cycle, when sister
chromatids are not yet formed.60 The question of the
relationship between HAC DNA reorganization and the cell
cycle timing of DNA transfection remains an important one for
future study.
The results described here have important implications for
ongoing efforts to build synthetic human chromosomes by de
novo synthesis,61 as has been done with great success for
budding yeast.62−64 Unlike budding yeast, which has a point
centromere,65 metazoans have regional centromeres that
require establishment of a proper epigenetic environment for
their function and stability.66−71 Our data suggest that this
process of centromere formation is frequently associated with
DNA rearrangements. It would be extremely unfortunate if
human chromosomes synthesized at great cost and effort were
to become scrambled in an uncontrollable fashion upon their
introduction to human host cells during the process of
centromere establishment.
Importantly, once centromere function is established, the
associated DNA arrays appear to be much more stable. In fact,
although some minor mutations were detected in some clones
when the ∼90 kb BRCA1 gene was inserted into an established
HAC vector (possibly the result of step 1), there was no
detected chromothripsis.12 Therefore, alternative strategies for
building synthetic chromosomese.g., assembly of synthetic
human chromosomes by building upon available HACs with a
multi-integrase site adjacent to the TetO-arraymay avoid
these complex DNA rearrangements.72
It will be important in future studies to use the alphoid2domain
HAC system to establish suitable conditions for conservation
of the organization of chromosome-sized DNA molecules
introduced into human cells during centromere establishment.
Routes that can be explored include the transfection of cell
lines in specific stages of the cell cycle when the DNA may be
less prone to undergo rearrangements (e.g., mitosis); the
cotransfection CENP-A or with TetR-linked coactivators of
kinetochore establishment (e.g., CENP-A chaperones) or the
inactivation of cGAS and other molecules of the cytoplasmic
DNA-sensing pathways. Future studies with HACs will allow
us to determine whether transfected HAC-seeding DNA does
undergo chromothripsis, and if so, how to minimize this. The
HAC system will also be useful for studies to optimize
procedures to increase the efficiency of centromere activation
and establishment of properly regulated cohesion on
exogenous DNA. Only when these technical issues have
been resolved it will be possible to form predetermined
artificial and synthetic chromosomes in human cells.
■ METHODS
Construction of BAC Carrying α21-ITetO and α21-
IILacO/Gal4 Arrays by Tandem Ligation Amplification. The
BAC clone pBAC11.32TW12.32GLII, carrying 32 copies of
the α21-IILacO/Gal4 12-mer following 32 copies of the α21-ITetO
11-mer was constructed in three steps describing below.
1. Construction of α21-IILacO/Gal4 alphoid 12-mer and
insertion into pBluescript vector. α21-IILacO/Gal4 alphoid
12-mer has been designed based on alphoid type II DNA
of chromosome #21, and it has been synthesized by
GENEART. The SpeI and NheI sites are located
respectively at left and right ends of the α21-IILacO/Gal4
12-mer to be inserted into pBluescript vector. The
vector and the 12-mer were joined using the
homologous recombination-based method (GENEART
Seamless Cloning and Assembly Kit, ThermoFisher
Scientific). The resulting plasmid carries one copy of
α21-IILacO/Gal4 12-mer accompanying unique NheI and
unique SpeI site at the ends.
2. Extension of the α21-IILacO/Gal4 12-mer insert in the
plasmid vector by repeating the tandem ligation. To
extend the length of the alphoid insert, the tandem
ligation was repeated until the plasmid harbored 8 copies
of the 12-mer using SpeI, NheI, and ScaI restriction
enzymes (NEB).29,73 Therefore, the band of the highest
molecular weight (16.6 kb for 8 copies) was excised after
PFGE and cloned into the BAC vector. The α21-ITetO
11-mer was designed based on the sequence of type I
alphoid 11-mer of chromosome #21 centromere.21
3. Extension of the α21-IILacO/Gal4 12-mer insert in the
BAC vector. Starting from the BAC clone carrying 8
copies of the α21-IILacO/Gal4 12-mer, the tandem ligation
was repeated until the 12-mer insert reached 32 copies
using SpeI, NheI, and KasI restriction enzymes (NEB).
Finally, 32 copies of α21-ITetO 11-mer has been cut out
from the BAC vector and ligated into the same vector of
α21-IILacO/Gal4 12-mer to obtain the final product,
pBAC11.32TW12.32GLII.
After each cloning step, the forming arrays were digested
with BamHI and NotI restriction enzymes (NEB) and
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analyzed on 1% agarose gel electrophoresis using 100 bp DNA
Ladder, Quick-Load 1 kb Extend DNA ladder or Low Range
PFG Marker (NEB).
Quantitative PCR (qPCR) to Detect BAC Copy
Number. Cells from HAC-containing clones have been
harvested and genomic DNA has been collected using Maxwell
DNA purification kit (Promega). qPCR analysis have been
performed using SYBR Green Master Mix (Roche) and the
following primers: N11F5: 5′-GGGATCACTAGCAAT-
AAAAGGTAGAC-3′ and N11R6: 5′-TCCTTCTGTC-
TCGTTTTTATGGC-3′ for the BAC synthetic DNA; 11−
10R: 5′-AGGGAATGTCTTCCCATAAAAACT-3′ and
mCbox-4: 5′-GTCTACCTTTTATTTGAATTCCCG-3′ for
the alphoid chr21 array as control. As a standard, DNA from a
previously characterized HAC-containing cell line (H21) with
a known number of BAC copies (n = 125) has been diluted
with serial dilutions and amplified with the same primers.
Cell Culture, Transfection, HAC Formation, and
Subcloning. Human HT1080 and HT1080 constitutively
expressing TetR-EYFP41 cells were cultured in DMEM
supplemented with 10% FBS (Labtech) plus 100 U/mL
penicillin G and 100 μg/mL of streptomycin sulfate
(Invitrogen). Cells were grown at 37 °C in 5%CO2 in a
humidified atmosphere. Transfection of pBAC11.32TW12.32-
GLII DNA was performed using Viafect (Promega) following
the manufacturer’s instructions. For transfections of cells
growing in 6-well plates, transfection complexes containing 10
μL of Viafect reagent and 1 μg of plasmid DNA were prepared
in 200 μL of OptiMEM (Invitrogen). After 5 min of
incubation at room temperature, 200 μL of transfection
complexes was added dropwise in 2 mL of media. After 6 h, the
media was changed to the wells and transfected cells were
selected adding 400 μg/mL of Geneticin (Thermo Fisher) and
grown for 2−3 weeks until separate resistant colonies were
present. Resistant colonies were isolated manually and moved
into 24-well plates. Isolated clones were expanded in the
presence of 400 μg/mL of Geneticin. For targeting experi-
ments with TerR-KAP1 and LacI-KAP1, cells have been
transfected using Xtremegene-9 (Roche) according to
manufacturer’s instructions. For transfections in 12-well plates,
transfection complexes containing 3 μL of Xtremegene-9
reagent and 500 ng of plasmid DNA were prepared in 100 μL
of OptiMEM (Invitrogen). After 20 min of incubation at room
temperature, 100 μL of transfection complexes was added
dropwise in 1 mL of media. For cotransfection, 500 ng of each
plasmid has been transfected in the same reaction.
Southern Blot Hybridization Analysis. Southern blot
hybridization was performed as described previously36 with
minor changes. Genomic DNA was prepared in agarose plugs
(Low Melt Agarose, Biorad), 0.5 × 106 cells per plug: plugs
have been treated with Proteinase K (CHEF genomic DNA
plug kit, Biorad) and restriction-digested by BamHI (NEB)
overnight in the buffer recommended by the manufacturer.
The digested DNA was CHEF (CHEF Mapper, Bio-Rad)
separated (autoprogram, 5−250 kb range, 16 h transfer),
transferred to membrane (Amersham Hybond-N+), and blot-
hybridized with an 82 bp probe for TetO and a 74 bp probe for
LacO and Gal4 containing P-32 CTP. Radioactive labeled
DNA sequences for the probes were synthesized by PCR using













south1_F1: 5′-AATGGACATTTCGACG-3′ , gal4_-
south1_R1: 5′-TAGATTTTATGCGGAG-3′).
The membrane was incubated for 2 h at 65 °C for
prehybridization in Church’s buffer (0.5 M Na-phosphate
buffer containing 7% SDS and 100 μg/mL of unlabeled salmon
sperm carrier DNA). The labeled probe was heat denatured in
a boiling water for 5 min, cooled, added to the hybridization
Church’s buffer, and allowed to hybridize for 48 h at 65 °C.
Blots were washed once in 2× SSC (300 mM NaCl, 30 mM
sodium citrate, pH 7.0)/0.05% SDS for 20 min at 30 °C, once
in 2× SSC/0.05% SDS for 10 min at 65 °C and then three
times in 2× SSC/0.05% SDS for 5 min at 65 °C. Blots were
exposed to X-ray film 2−48 h at −80 °C.
Expression and Purification of Recombinant TetR/
LacI-eYFP. TetR and LacI were cloned as C-terminally His-
tagged proteins in a pET23a vector and proteins were purified
following a previously described procedure.9 Briefly, the
vectors were transformed in E. coli BL21 Gold cells and
colonies grown at 37 °C until OD6001 in Super Broth
containing ampicillin. The cultures were then induced with
0.35 mM IPTG overnight at 18 °C and cell pellets were lysed
in a buffer containing 20 mM Tris HCl pH 7.5, 500 mM NaCl,
35 mM imidazole and 2 mM 2-mercaptoethanol. Proteins were
affinity-purified using a Ni-NTA column (GE Healthcare),
washed with high salt buffer (20 mM Tris HCl pH 7.5, 1000
mM NaCl, 50 mM KCl, 10 mM MgCl2, 2 mM ATP, 35 mM
imidazole, and 2 mM 2-mercaptoethanol) and eluted with 20
mM Tris HCl pH 7.5, 150 mM NaCl, 400 mM imidazole, and
2 mM 2-mercaptoethanol. The pure eluted fractions were
pooled and dialyzed overnight against storage buffer (20 mM
Tris HCl pH 7.5, 150 mM NaCl, 5% glycerol, and 2 mM 2-
mercaptoethanol). Sample quality was analyzed by 15% SDS-
PAGE stained with Coomassie Blue. The final protein
concentrations that were used for the IF staining on fibers
were 1.2 and 1.7 mg/mL for TetR-eYFP and LacI-eYFP,
respectively.
Fluorescent in Situ Hybridization (FISH) and DNA
Fibers Preparation. Metaphase chromosomes from HT1080
were obtained following a standard protocol: 3 h before
harvesting, cells were treated with Colcemid (Invitrogen) at a
final concentration of 0.1 μg/mL. Collected cells were
resuspended in warm hypotonic solution (75 mM KCl) for
20 min at 37 °C and fixed in methanol:acetic acid (3:1). Slides
were kept at −20 °C until they were processed for FISH. To
obtain stretched chromatin fibers, 2 × 106 cells were
centrifuged, and the pellets were washed in 1× PBS. Ten μL
drops have been placed on slides and let dry. Once the slides
were mounted on the Shandon Sequenza cover plates
(Thermo Scientific), DNA fibers were released applying a
lysis solution (700 mM NaOH in ethanol) and fixed in
methanol. Slides have been kept in PBS at 4 °C until stained.
For oligo-FISH staining, oligonucleotides recognizing the
TetO sequence (5′-ACTAGCAGCAGAGCTCTCCC-
TATCAGTGATAGAGACTAG-3′) labeled with Digoxigenin,
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and oligonucleotides recognizing both LacO (5′-CATGT-
GGAATTGTGAGCGGATAACAATTTGTGG-3′) and Gal4
(5′-TCGACGGAGGACAGTCCTCCG-3′) sequences labeled
with Biotin were purchased (Sigma). Oligonucleotides were
mixed at 100 ng/μL and resuspended in hybridization buffer
(50% formamide, 10% dextran sulfate, 2× SSC (300 mM
NaCl, 30 mM sodium citrate, pH 7.0)) and 50 μg/mL of
salmon sperm DNA (Sigma). FISH was carried out following
standard procedures. Slides were denatured in 70% forma-
mide/2× SSC at 68 °C for 45 s (70 °C for 1 min for fibers)
and hybridized in a humid chamber at 37 °C for 2 h. Slides
were then washed in 20%formamide/2× SSC for 5 min and in
2× SSC/0.1% Tween-20 for 5 min at 37 °C. Oligonucleotide
probes were detected with rhodamine-conjugated antidigox-
igenin (Roche) and fluorescein-conjugated streptavidin
(Vector Laboratories) incubated for 30 min at 37 °C. Slides
were mounted with Vectashield (Vector Laboratories)
containing 4′,6-diamidino-2-phenylindole (DAPI) for chromo-
some counterstaining. IF staining on fibers, slides have been
blocked with 1% BSA/1× PBS/0.1% Triton X-100 and then
incubated with TetR-GFP or LacI-GFP proteins purified from
E. coli in blocking buffer overnight at 4 °C, together with α-
CENP-A and α-H3K9me3 antibodies as described in
immunofluorescence (IF) protocol. Slides have been washed,
incubated with secondary antibodies and sealed as immuno-
fluorescence (IF) staining standard protocol. For the IF
staining on fibers, we aimed to count 20−30 fibers for each
staining.
Analysis of the HAC Stability. HAC-containing sub-
clones have been thawed and maintained in culture with 400
μg/mL of Geneticin (Thermo Fisher) for 7 days. At day 0,
metaphase chromosomes have been spread on slides and
labeled for FISH as described. At day 0, cell cultures have been
split into two batches: one batch has been kept in culture with
400 μg/mL of Geneticin (Thermo Fisher) for 30 days, while
the other has been kept in culture with simple DMEM/10%
FBS/1% PenStrepto. At day 30, metaphase chromosomes from
each batch have been spread on slides and labeled for FISH as
described. Metaphases at day 0 and day 30 have been scored
for the presence of 0, 1, 2, or >2 HACs. The daily loss rate of
the HAC (R) was calculated using the formula Nn = N0 × (1 −
R)n, where N0 is the number of metaphase chromosome
spreads showing a HAC in the cells cultured under selection
and Nn is the number of HAC-containing metaphase
chromosome spreads after n days of culture in the absence
of selection.
Indirect Immunofluorescence (IF) Staining and
Microscopy Analysis. Indirect immunofluorescence (IF)
staining of cells fixed in 3.7% formaldehyde/1× PBS was
performed at 37 °C for 10 min following standard procedures.
The following antibodies were used: mouse anti-CENP-A
(clone A1, 1:50037) and rabbit anti-H3K9me3 (abcam 8898;
1:300). Microscope images were acquired on a DeltaVision
Core system (Applied Precision) using an Olympus IX-71
inverted microscope stand with an Olympus UPlanSApo 100×
oil immersion objective (numerical aperture (NA) 1.4) and an
LED light source. Camera (Photometrics Cool Snap HQ),
shutter, and stage were controlled through SoftWorx (Applied
Precision). Z-series were collected with a spacing of 0.2 μm,
and image stacks were subsequently deconvolved in SoftWorx.
CENP-A and H3K9me3 signal quantification at the HAC was
performed using ImageJ. HAC was visualized in the green
channel thanks to the tethering of the corresponding
fluorescent protein. For CENP-A signal quantification, a
custom-made macro in ImageJ (National Institutes of Health,
Bethesda, MD) was used.74
Chromatin Immunoprecipitation and Quantitative
PCR (ChIP-qPCR). Exponentially growing cells were harvested
with TrypLE Express (Gibco) and resuspended in D-PBS
(Gibco) up to a concentration of 1 × 106 cells/mL. They were
cross-linked with 1% formaldehyde solution (Sigma) for 5 min
at room temperature, followed by quenching with 2.5 M
glycine for 5 min at room temperature. Cells at a concentration
of 5 × 106 cells/mL were lysed in lysis buffer (10 mM Tris pH
8.0; 10 mM NaCl; 0.5% NP-40) containing protease inhibitors
(1 μg/mL of CLAP; 0.5 μg/mL of Aprotinin; 1 mM PMSF)
for 10 min on ice. Cells pellets have been snap-frozen in liquid
N and stored in −80 °C until processed. Nuclei were
resuspended in lysis buffer with protease inhibitors (50 mM
Tris pH 8.0; 2 mM EDTA; 0.2% SDS; 134 mM NaCl; 0.88%
Triton X-100; 0.088% Na-deoxycholate) and incubated with
400 U/mL MNase for 30 min at 20 °C. Chromatin was
sheared by sonication in a Bioruptor sonicator (Diagenode) for
9 cycles (30s ON/30s OFF) at high setting and 4 °C in
dilution buffer 1 enriched with. The collected supernatants
after sonication were diluted with 300 μL of dilution buffer 1,
500 μL of dilution buffer 2 (50 mM Tris pH 8.0; 167 mM
NaCl; 1.1% Triton X-100; 0.11% Na-deoxycholate), and 500
μL of RIPA buffer containing 150 μL of NaCl (RIPA-150) and
protease inhibitors. Antimouse IgG Dynabeads (Invitrogen)
were conjugated with the relevant antibodies for 6 h with
RIPA-150/0.5% BSA at 4 °C and washed twice with RIPA-
150/0.5% BSA. 500 μL of collected sheared chromatin was
incubated with the beads at 4 °C overnight. Beads were
afterward washed twice with RIPA-150 and RIPA buffer
containing 500 mM NaCl (RIPA-500) and a final wash with
TE pH 8.0. Antibody/chromatin complexes were de-cross-
linked with 10% Chelex-100 resin (BioRad) in water at 93 °C
and incubated with RNase A and Proteinase K. DNA was
subsequently recovered using magnetic rack. DNA from the
chromatin immunoprecipitates (ChIPed DNA) and input
DNA was subject to real-time PCR analysis using a SYBR
Green Mastermix (Roche) on a LightCycler480 system
(Roche). For each primer pair, a standard curve was prepared
from the input material and included on every plate to
calculate the percent of precipitated DNA relative to the input
material. ChIPed DNA was subjected to RT-PCR using the
following oligonucleotides: tetO-Fw (5′-CCACTCCCTA-
TCAGTGATAGAGAA-3′), tetO-Rv (5′-TCGACTTCTG-
TTTAGTTCTGTGCG-3′) for the α21-I-tetO domain of
the hybrid HAC, lacOgal4-Fw (5′-TATGGTGTCGACGGA-
GGACA-3′), and lacOgal4-Rv (5′-CCGCTCACAATTCCA-
CATGTG-3′) for the α21-II-lacOgal4 domain of the hybrid
HAC, chr17-Fw (5′-TTGTGGTTTGTGGTGGAAAA-3′)
and chr17-Rv (5′-CTCAAAGCGCTCCAAATCTC-3′) for
the alphoid chr17 array, sat2-Fw (5′-TCGCATAGAATCGAA-
TGGAA-3′) and sat2-Rv (5′-GCATTCGAGTCCGTGGA-3′)
for the pericentromeric alphoid chr1.
IF during Early Stages of Alphoid2domain HAC
Formation. HT1080 and HT1080 constitutively expressing
TetR-EYFP,41 both growing on coverslips, were transfected
with pBAC11.32TW12.32GLIIusing Viafect (Promega) as
already described. Transfected cells were fixed at the stated
time points following IF procedures and stained using mouse
anti-CENP-A (clone A1, 1:50037). Microscope images were
acquired on a DeltaVision Core system (Applied Precision).
ACS Synthetic Biology pubs.acs.org/synthbio Research Article
https://dx.doi.org/10.1021/acssynbio.0c00326
ACS Synth. Biol. 2020, 9, 3267−3287
3283
For HT1080, cells were transfected with LacI-GFP plasmid to
localize the HAC DNA 18−24 h prior fixation.
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